Cc1cc2[nH]c3c(C#N)c(-c4ccccc4)c(/N=N/c4ccc(F)cc4)c(=O)n3c2cc1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?